drugset / Trial / NCT00003013

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

NCT00003013

RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining surgery with chemotherapy may kill more tumor cells. It is not yet known which treatment regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy plus surgery in treating women who have breast cancer.

Timeline

Start
1996-10
Primary completion
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified 60 mg/m2 Intravenous
Subject Doxorubicin Other / unclassified 75 mg/m2 Intravenous
Subject Paclitaxel Small molecule 200 mg/m2 Intravenous
Background Cyclophosphamide Other / unclassified Intravenous
Background Methotrexate Small molecule Intravenous
Background Tamoxifen Small molecule Oral
Background fluorouracil Small molecule Intravenous